Speakers
What makes blockbusters and breakthrough therapeutics tick?
What makes a new treatment a Drug to Watch? Clarivate analysts discuss four of this year’s picks and what made them pop, including:
- Novel mechanisms of action
- Convenience and adherence
- Addressing treatment gaps
- Combination approaches
- Potential for labor expansions
- Competitive landscape
Learn more about what made Cagrisema, COBENFY, mRESVIA and zanzalintinib 2025 Drugs to Watch in this on-demand webinar.
